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1Regulación  inmune  anormal  en  nin˜os
Irritable  bowel  syndrome  (IBS)  is  regarded  as  a  multifactorial
disorder,  but  there  has  been  evidence  over  the  last  few  years
leading  to  the  proposal  of  the  presence  of  abnormal  immune
regulation  due  to  a  decrease  in  anti-inﬂammatory  cytokines
and  an  increase  in  the  proinﬂammatory  ones.1 For  example,
a  systematic  review  suggested  the  presence  of  low  levels
of  IL-10  in  blood  with  increased  levels  of  proinﬂammatory
cytokines,  even  though  the  results  were  inconsistent.2 In
a  recent  meta-analysis  by  Bashashati  et  al.  that  analyzed
IL-10  and  TNF- levels,  no  differences  were  found  in  IL-10
between  subjects  with  IBS  and  controls.  However,  upon  ana-
lyzing  differences  in  relation  to  sex,  IL-10  levels  were  lower
in  men  with  IBS  vs  men  in  the  control  group.3 Furthermore,
TNF-  levels  tended  to  be  higher  in  the  IBS  subjects,  com-
pared  with  the  controls.3 In  IBS,  increased  proinﬂammatory
cytokines  derived  from  peripheral  blood  mononuclear  cells
(PBMC)  have  also  been  shown  in  both  the  baseline  period,  as
well  as  after  bacterial  lipopolysaccharide  (LPS)  stimulation.4
In  addition,  lower  IL-10  mRNA  expression  in  the  colonic
mucosa  has  been  reported  in  patients  with  IBS  vs  healthy
controls.5 Nevertheless,  all  these  data  are  from  studies  car-
ried  out  on  adults.
In  this  issue  of  the  Revista  de  Gastroenterología  de
México,  Vázquez-Frias  et  al.  published  what  is  perhaps
the  ﬁrst  study  on  the  pediatric  population  that  analyzes
the  free  plasma  levels  of  anti-inﬂammatory  and  proinﬂam-
matory  cytokines  in  Mexican  patients  with  IBS  based  on
the  Rome  III  criteria,  compared  with  healthy  controls.6
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hey  emphasize  four  ﬁndings:  1)  lower  anti-inﬂammatory
ytokine  IL-10  levels  in  IBS;  2)  higher  proinﬂammatory
L-12  levels  in  IBS;  3)  higher  levels  of  TGF-, and
)  increased  levels  of  proinﬂammatory  TNF- in  both
BS  patients  and  controls,  with  no  differences  between
hem.6
.  In  relation  to  the  low  levels  of  IL-10  in  IBS  reported
in  the  present  study,  this  ﬁnding  coincides  with  an
analysis  from  Taiwan,  the  only  other  study  conducted
on  children  with  IBS  vs  controls.7 However,  unlike  the
study  by  Vázquez-Frias  et  al.,6 Hua  et  al.  analyzed  IL-
10  in  the  supernatant  of  PBMC  cultures  stimulated  by
Escherichia  coli  LPS.7 Lower  IL-10  levels  in  IBS  is  in  agree-
ment  with  studies  which  suggest  a  protective  role  for
high  producer  IL-10  gene  polymorphisms  in  this  func-
tional  disorder,8,9 although  in  Mexican  patients  there
was  a  greater  frequency  of  the  low  producer  IL-10  just
in  patients  with  diarrhea-predominant  IBS  (IBS-D).10 In
addition,  the  reduced  levels  of  IL-10  in  plasma  in  Mexican
children  with  IBS  vs  controls  also  concurs  with  a previous
study  carried  out  on  adults  in  Mexico  that  found  lower
levels  of  IL-10  in  volunteers  with  IBS  vs  controls.11 In  that
study,  IBS  and  female  sex  were  independent  predictors  of
low  IL-10  levels,  and  women  with  diarrhea-predominant
IBS  (IBS-D)  presented  with  lower  levels  of  that  cytokine.11
Vázquez-Frias  et  al.  did  not  make  comparisons  based  on
sex  and  did  not  provide  information  on  the  race  and
ethnicity  of  the  children  in  each  group.  Although  one
may  speculate  that  the  children  were  mestizo  as  the
majority  of  the  Mexican  population,  an  analysis  of  the
genomic  diversity  has  provided  evidence  of  genetic  dif-
ferences  between  Mexican  subpopulations12 that  should
be  considered  in  the  design  and  analysis  of  associa-
tion  studies  of  complex  diseases  such  as  IBS.  Further,
the  results  of  the  meta-analysis  that  suggested  that  the
IL-10  rs1800872  (-592A/C)  polymorphisms  were  associ-
ated  with  an  increased  risk  of  IBS  in  Asian  ethnicity8
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underscores  the  importance  of  providing  demographic
information  of  the  subjects  of  the  study.
.  The  higher  levels  of  the  proinﬂammatory  cytokine,  IL-
12,  in  the  present  study  are  controversial.  On  the  one
hand,  Kindt  et  al.  found  lower  IL-12  expression  in  LPS-
stimulated  monocytes  in  adults  with  IBS  vs  controls  in  a
Belgian  study  on  adults.13 Moreover,  in  China,  Fu  et  al.
found  no  differences  in  IL-12  peripheral  blood  levels  or  in
its  expression  in  the  colonic  mucosa  in  IBS  vs  controls,14
and  no  relation  was  found  between  the  IL-12  (-1188  C/A)
polymorphism  and  IBS  either,  all  of  which  makes  the  asso-
ciation  of  this  cytokine  with  IBS  uncertain.15
.  The  higher  levels  of  TGF- in  children  with  IBS,  is  a
novel  ﬁnding.  The  role  that  TGF- plays  in  IBS  is  still
unknown,  but  it  could  be  related  to  the  production  of
IL-10  from  Th1  cells.16 Also,  TGF1 is  a  multifunctional
cytokine  that  may  be  associated  with  gastrointestinal
and  extraintestinal  processes.  Moreover,  in  a  post-
infectious  IBS  (PI-IBS)  murine  model,  TGF-1 mRNA
expression,  together  with  that  of  other  cytokines,  incre-
mented  in  the  longitudinal  muscle  of  the  jejunum  during
acute  infection  with  Trichinella  spiralis.17 Later,  in  the
PI-IBS  phase,  TGF-1 remained  elevated,  whereas  the
Th2  cytokines  returned  to  their  normal  values.  Likewise,
the  incubation  of  muscle  tissue  with  IL-4,  IL-13  increased
the  level  of  TGF-1. Similarly,  the  incubation  of  tissue
with  Th2  cytokines  induced  muscle  hypercontractility
due  to  TGF-1 expression  and  an  over-regulation  of  COX-
2  and  PGE  2  at  the  smooth  muscle  cell  level.17 Therefore,
TGF-1  may  be  related  to  smooth  muscle  hyperactivity
which  may  potentially  increase  bowel  motility  in  IBS.
.  The  absence  of  differences  in  TNF- in  children  with  IBS
vs  controls  contrasted  with  the  study  on  adults  in  Mex-
ico,  in  which  higher  levels  of  this  cytokine  were  found
in  subjects  with  IBS  vs  controls.11 One  possibility  is  that
a  pathologic  stimulus  is  required,  raising  the  levels  of
TNF-  throughout  a  person’s  lifetime  and  exacerbating
IBS;  a  follow-up  of  this  cohort  would  be  necessary  in
order  to  determine  what  occurs  in  later  years  of  age.
In  fact,  in  Mexico,  it  appears  that  TNF- in  IBS  is  not
genetically  determined,  given  that  no  differences,  at
least  not  in  the  -308G/A  polymorphism,  were  found.10
However,  an  important  ﬁnding  of  the  present  study  is
the  high  TNF- levels  in  the  children  with  IBS,  as  well
as  in  the  controls.  This  seems  to  be  related  to  the
kit  utilized  in  the  analysis6 and  should  be  taken  into
consideration  when  making  comparisons  with  different
studies.
In  conclusion,  the  study  by  Vázquez-Frias  et  al.  shows
hat  children  with  IBS,  like  adults,  present  with  an  alter-
tion  in  immune  regulation.  Low  plasma  levels  of  IL-10  could
ecome  an  IBS  biomarker  in  Mexico.  In  addition,  further
tudies  are  required  to  determine  the  role  of  TGF- in  IBS.
ongitudinal  studies  comparing  cytokine  levels  in  children
ith  IBS  with  active  symptoms  and  asymptomatic  children
ith  a  history  of  IBS  could  help  clarify  their  role  in  the
athophysiology  of  IBS.  Moreover,  it  is  important  to  ana-
yze  circulating  cytokine  levels  as  well  as  cytokine  secretion
ased  on  IBS  subtypes  and  the  presence  of  PI-IBS  and  the
eed  for  comparative  studies  on  different  populations,  uti-
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izing  not  only  the  same  diagnostic  criteria,  but  also  the
ame  laboratory  methods.
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